Peripheral arterial disease

Original Research

Examining Sex-Based Differences Among Individuals With Peripheral Arterial Disease in Southwest Louisiana: A Secondary Data Analysis

02/16/2023

Michael A. Neal , DNP, CRNA, MSN;

Jill R. Engel , DNP, ACNP, FNP, NEA-BC, FAANP;

Gregory D. Trachiotis , MD;

Christian D. Nagy , MD;

Exploring the relationship between sex and determinants of PAD and symptom severity, treatments offered, and outcomes.

Exploring the relationship...

02/16/2023

Vascular Disease Management

Editor's Corner

BEST-CLI Deep Dive II

12/15/2022

Craig M. Walker , MD, FACC, FACP, FSCAI, FCCP;

Dr. Walker continues his discussion of the BEST-CLI randomized control trial comparing surgery-first with or without an adequate venous conduit vs endovascular-first treatment in patients with CLTI.

Dr. Walker continues his...

12/15/2022

Vascular Disease Management

Original Research

Post-market, Prospective Evaluation of Photo-oxidized Decellularized Bovine Pericardium Used as a Patch in Vascular Repair and Reconstruction Surgery: PHOTO-V

12/14/2022

Nicholas Morrissey, MD¹; B. Timothy Baxter, MD²; Michael Belkin, MD³; William T. Bohannon, MD, FACS⁴; Jose Borromeo, MD, FACS⁵; Nitin Garg, MBBS, MPH⁶; Larry Kraiss, MD⁷; Nicholas Osborne, MD⁸; Todd Russell, MD, FACS⁹; Wei Zhou, MD¹⁰

¹Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, Division of Vascular Surgery and Endovascular Interventions, New York, New York; ²University of Nebraska Medical Center, Omaha, Nebraska; ³Brigham & Women's Hospital, Boston, Massachusetts; ⁴Baylor Scott & White, Temple, Texas; ⁵Iowa Heart Center, West Des Moines, Iowa; ⁶Peak Heart and Vascular, Avondale, Arizona; ⁷University of Utah School of Medicine, Salt Lake City, Utah; ⁸University of Michigan, Ann Arbor, Michigan; ⁹Jobst Vascular Institute, Toledo, Ohio; ¹⁰University of Arizona, Tucson, Arizona

Nicholas Morrissey, MD1; B. Timothy B...

This article reports the results from the first clinical study of a BPP processed through photo-oxidation, without the use of glutaraldehyde, in procedures for CAS, as well as PAD.

This article reports the results...

12/14/2022

Vascular Disease Management

OBL Corner

The Value of Outpatient Based Labs for Endovascular Therapy of Peripheral Artery Disease: The Cardiovascular Institute of the South Experience

11/16/2022

Lauren W.M. Swager , MD;

Pradeep K. Nair , MD, FACC, FSCAI;

A review of the safety, efficacy, and outcomes of lower extremity endovascular intervention in patients with symptomatic PAD.

A review of the safety,...

11/16/2022

Vascular Disease Management

Marmagkiolis Endovascular Therapy Table 1

Original Contribution

Superficial Femoral Artery Endovascular Therapy: 12-Month Primary Patency Rates of Contemporary Endovascular Devices from 25,051 Patients

10/20/2022

Ismail Dogu Kilic , MD;

Mehmet Cilingiroglu , MD;

Abrahim Halil Inanc , MD;

Muhammad Ajmal , MD;

Cezar A. Iliescu , MD, FACC, FSCAI;

Konstantinos Marmagkiolis , MD, MBA, FACC, FSCAI;

Approximately 5.8 million people experience peripheral arterial disease (PAD) in the United States today. Superficial femoral artery (SFA) disease is the most common cause of symptomatic PAD. New-generation nitinol stents, drug-coated stents,...

Approximately 5.8 million people...

10/20/2022

Journal of Invasive Cardiology

Commentary

Is There a Role for Edetate Disodium Chelation in PAD and Specifically CLTI?

10/12/2022

Francisco Ujueta , MD, MS;

Gervasio A. Lamas , MD;

In this commentary, the authors review edetate disodium chelation therapy and its use in patients with PAD and CLTI.

In this commentary, the authors...

10/12/2022

Vascular Disease Management

Scientific Abstracts

Abstracts From the Amputation Prevention Symposium (AMP), August 17-20, 2022, Chicago, Illinois

09/20/2022

Read the abstracts that were submitted to AMP, which took place August 17-20, 2022, in Chicago, Illinois. These abstracts cover a variety of topics, with a focus on PAD, CLI, and amputation prevention.

Read the abstracts that were...

09/20/2022

Vascular Disease Management